Register entryShortage reported
- Registered sites
- 0
- Active NDC listings
- 15
- Live patents
- 21
- Shortage listings
- 11
- Countries
- 0
Alert
Drug shortage listings
11| Drug | Presentation | Status | Availability | Posted / updated |
|---|---|---|---|---|
| Methylphenidate Hydrochloride Tablet, Extended ReleasePsychiatry | Relexxii, Tablet, Extended Release, 54 mg (NDC 68025-098-10) | Current | Available | 26 Jul 20231 Oct 2026 |
| Methylphenidate Hydrochloride Tablet, Extended ReleasePsychiatry | Relexxii, Tablet, Extended Release, 54 mg (NDC 68025-098-30) | Current | Available | 26 Jul 20231 Oct 2026 |
| Methylphenidate Hydrochloride Tablet, Extended ReleasePsychiatry | Relexxii, Tablet, Extended Release, 36 mg (NDC 68025-097-30) | Current | Available | 26 Jul 20231 Oct 2026 |
| Methylphenidate Hydrochloride Tablet, Extended ReleasePsychiatry | Relexxii, Tablet, Extended Release, 18 mg (NDC 68025-095-10) | Current | Available | 26 Jul 20231 Oct 2026 |
| Methylphenidate Hydrochloride Tablet, Extended ReleasePsychiatry | Relexxii, Tablet, Extended Release, 18 mg (NDC 68025-095-30) | Current | Available | 26 Jul 20231 Oct 2026 |
| Methylphenidate Hydrochloride Tablet, Extended ReleasePsychiatry | Relexxii, Tablet, Extended Release, 45 mg (NDC 68025-088-30) | Current | Available | 26 Jul 20231 Oct 2026 |
| Methylphenidate Hydrochloride Tablet, Extended ReleasePsychiatry | Relexxii, Tablet, Extended Release, 36 mg (NDC 68025-097-10) | Current | Available | 26 Jul 20231 Oct 2026 |
| Methylphenidate Hydrochloride Tablet, Extended ReleasePsychiatry | Relexxii, Tablet, Extended Release, 27 mg (NDC 68025-096-30) | Current | Available | 26 Jul 20231 Oct 2026 |
| Methylphenidate Hydrochloride Tablet, Extended ReleasePsychiatry | Relexxii, Tablet, Extended Release, 27 mg (NDC 68025-096-10) | Current | Available | 26 Jul 20231 Oct 2026 |
| Methylphenidate Hydrochloride Tablet, Extended ReleasePsychiatry | Relexxii, Tablet, Extended Release, 63 mg (NDC 68025-089-30) | Current | Available | 26 Jul 20231 Oct 2026 |
| Methylphenidate Hydrochloride Tablet, Extended ReleasePsychiatry | Relexxii, Tablet, Extended Release, 72 mg (NDC 68025-084-30) | Current | Available | 26 Jul 20231 Oct 2026 |
Catalogue
Drug listings by form and route
1515 active NDC listings: 15 human prescription drug. By marketing category: NDA 15.
| Dosage form | NDCs |
|---|---|
| tablet, extended release | 7 |
| gel | 5 |
| capsule, extended release | 3 |
| Route | NDCs |
|---|---|
| oral | 10 |
| topical | 5 |
| Labeller name on the listing | NDCs |
|---|---|
| vertical pharmaceuticals, llc | 15 |
Exclusivity
Patents and exclusivities
21| Patent | Product | Covers | Expiry |
|---|---|---|---|
| 10245228 | DSUVIAsufentanil citrate | product | Jan 2027 |
| 10342762 | DSUVIAsufentanil citrate | product | Jan 2027 |
| 10507180 | DSUVIAsufentanil citrate | product | Jan 2027 |
| 8226978 | DSUVIAsufentanil citrate | product | Jan 2027 |
| 8231900 | DSUVIAsufentanil citrate | product | Jan 2027 |
| 8252328 | DSUVIAsufentanil citrate | product | Jan 2027 |
| 8252329 | DSUVIAsufentanil citrate | product | Jan 2027 |
| 8535714 | DSUVIAsufentanil citrate | product | Jan 2027 |
| 8778393 | DSUVIAsufentanil citrate | use | Jan 2027 |
| 8778394 | DSUVIAsufentanil citrate | use | Jan 2027 |
| 8865211 | DSUVIAsufentanil citrate | use | Jan 2027 |
| 9320710 | DSUVIAsufentanil citrate | use | Jan 2027 |
| 9744129 | DSUVIAsufentanil citrate | product | Jan 2027 |
| 10896751 | DSUVIAsufentanil citrate | product | Mar 2030 |
| 11676691 | DSUVIAsufentanil citrate | product | Mar 2030 |
| 12033733 | DSUVIAsufentanil citrate | product | Mar 2030 |
| 8574189 | DSUVIAsufentanil citrate | product | Mar 2030 |
| 8202535 | DSUVIAsufentanil citrate | use | Oct 2030 |
| 8865743 | DSUVIAsufentanil citrate | use | Oct 2030 |
| 8945592 | DSUVIAsufentanil citrate | product | Jul 2031 |
| 11672738 | DSUVIAsufentanil citrate | product | Feb 2038 |
Catalogue
Marketed products
15| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| ConZip | tramadol hydrochloride | capsule, extended release, oral | 68025-071NDA |
| ConZip | tramadol hydrochloride | capsule, extended release, oral | 68025-072NDA |
| ConZip | tramadol hydrochloride | capsule, extended release, oral | 68025-073NDA |
| DIVIGEL | estradiol | gel, topical | 68025-065NDA |
| DIVIGEL | estradiol | gel, topical | 68025-066NDA |
| DIVIGEL | estradiol | gel, topical | 68025-067NDA |
| DIVIGEL | estradiol | gel, topical | 68025-083NDA |
| DIVIGEL | estradiol | gel, topical | 68025-086NDA |
| RELEXXII | methylphenidate hydrochloride | tablet, extended release, oral | 68025-084NDA |
| RELEXXII | methylphenidate hydrochloride | tablet, extended release, oral | 68025-088NDA |
| RELEXXII | methylphenidate hydrochloride | tablet, extended release, oral | 68025-089NDA |
| RELEXXII | methylphenidate hydrochloride | tablet, extended release, oral | 68025-095NDA |
| RELEXXII | methylphenidate hydrochloride | tablet, extended release, oral | 68025-096NDA |
| RELEXXII | methylphenidate hydrochloride | tablet, extended release, oral | 68025-097NDA |
| RELEXXII | methylphenidate hydrochloride | tablet, extended release, oral | 68025-098NDA |
Compare
Other companies listing methylphenidate hydrochloride
- Novartis Pharmaceuticals Corporation20 sites · 210 NDC
- Sandoz Industrial Products S.A5 sites · 441 NDC
- SpecGx LLC5 sites · 237 NDC
- Actavis LLC1 site · 309 NDC
- Lannett Company, LLC1 site · 190 NDC
- Societal CDMO Gainesville, LLC1 site · 55 NDC
- NextWave Pharmaceuticals, Inc0 sites · 13 NDC
- Aytu Therapeutics, LLC0 sites · 11 NDC
Enquiry
Common questions
- Is Vertical Pharmaceuticals, LLC FDA approved?
- Vertical Pharmaceuticals, LLC holds no registered establishment of its own; 15 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does Vertical Pharmaceuticals, LLC make?
- 15 products are listed under Vertical Pharmaceuticals, LLC in the openFDA NDC Directory, most often as tablet, extended release; gel; capsule, extended release. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
- Are any Vertical Pharmaceuticals, LLC products in shortage?
- 11 presentations are currently listed in the FDA drug shortage database under Vertical Pharmaceuticals, LLC, covering Methylphenidate Hydrochloride Tablet, Extended Release.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.